Diabetes Treatment Denied in Florida: Appeal Guide

Florida has one of the largest diabetes populations in the United States, with over 2.6 million adults diagnosed — and the state's large elderly population means Medicare and Medicare Advantage plans are especially relevant. If your insurer has denied coverage for insulin, a continuous glucose monitor (CGM), an insulin pump, or medications like Ozempic or Mounjaro, Florida law provides clear rights to appeal, and many denials can be overturned with the right approach.

The Florida Insurance Landscape for Diabetes

Florida's insurance market is served by major carriers including Florida Blue (Blue Cross Blue Shield of Florida), Aetna, UnitedHealthcare, Humana, Molina, and Centene/WellCare. Florida Blue dominates both the employer-sponsored and individual marketplace, while Humana and UnitedHealthcare have a large Medicare Advantage presence — critical given Florida's retiree population.

Florida does not require insurers to cover all diabetes-related treatments without restriction, but state law mandates coverage of diabetes equipment and supplies, medications, and self-management education for insured plans. The federal ACA's essential health benefit requirements also apply to marketplace and small group plans.

Florida's Insulin Cost-Cap Law

Florida enacted legislation capping insulin out-of-pocket costs at $35 per 30-day supply for patients with state-regulated insurance. This applies to fully insured individual and group plans regulated by the Florida Office of Insurance Regulation. Self-funded ERISA plans from large employers are federally regulated and may not be subject to this state cap.

If you are paying more than $35/month for insulin under a qualifying plan, report this to the Florida Office of Insurance Regulation.

Medicaid (Florida Medicaid) and Diabetes

Florida operates its Medicaid program through managed care organizations under the Statewide Medicaid Managed Care (SMMC) program. Florida did not expand Medicaid under the ACA until 2023, and coverage remains limited for many low-income adults without children. Medicaid covers insulin, oral diabetes medications, blood glucose monitors, and test strips.

CGM coverage under Florida Medicaid is available but subject to Prior Authorization Denied: How to Appeal" class="auto-link">prior authorization requirements. Patients must typically demonstrate insulin dependence and a documented need for continuous monitoring. If your Florida Medicaid plan denied a CGM, request a fair hearing through the Florida Department of Children and Families (DCF).

Common Denials in Florida

GLP-1 Drugs (Ozempic, Mounjaro, Wegovy, Rybelsus): Prior authorization and step therapy are the norm across Florida's commercial insurers. Ozempic (semaglutide) is commonly denied when prescribed for Type 2 diabetes if the insurer categorizes it primarily as a weight-loss drug rather than a glucose-lowering agent. Your physician's documentation should emphasize the A1C-lowering indication and diabetes diagnosis code.

CGMs: Florida Blue and other carriers frequently deny CGMs for Type 2 patients not on intensive insulin therapy, citing outdated criteria that contradict current ADA standards. A letter from your endocrinologist or primary care physician citing hypoglycemia risk is often the most effective rebuttal.

Insulin Pumps: Require documentation of failed MDI therapy and typically need an endocrinologist's attestation. Some plans require a 3-6 month trial of injections before pump approval.

Specialist Referrals: Florida's managed care plans often require in-network referrals for endocrinologists, and out-of-network denials are common.

How to Appeal a Diabetes Denial in Florida

1. Request your denial letter and the plan's medical necessity criteria. Florida law requires insurers to provide written denial reasons.
2. Obtain a detailed letter of medical necessity from your treating physician. Reference the ADA's Standards of Medical Care in Diabetes and your documented clinical history (A1C levels, hypoglycemia episodes, complications).
3. File an internal appeal within your plan's deadline — typically 180 days from the denial. Florida insurers must resolve standard appeals within 30 days, and urgent appeals within 72 hours.
4. Request an external appeal through the Florida Department of Financial Services if the internal appeal is denied. Florida provides an independent review process for adverse benefit determinations.
5. File a complaint with the Florida Office of Insurance Regulation at 1-877-693-5236 or floir.com.

For Medicare Advantage plan denials, the appeals process runs through the plan and then to a Qualified Independent Contractor (QIC) review under CMS rules. Contact 1-800-MEDICARE for guidance.

State Insurance Department Contact

Florida Office of Insurance Regulation (OIR)

• Phone: 1-877-693-5236
• Website: floir.com

Florida Department of Financial Services (DFS)

• Phone: 1-877-693-5236
• Website: myfloridacfo.com/division/consumer

Additional Resources

The American Diabetes Association (diabetes.org) has extensive resources for Florida patients, including advocacy contacts and appeal letter guidance. For Medicare Advantage patients, the State Health Insurance Assistance Program (SHIP) offers free counseling at 1-800-963-5337.

Florida's appeals process is accessible, and independent reviewers overturn a meaningful percentage of diabetes-related denials when strong clinical documentation is provided. Do not give up after a single denial.

Fight Back With ClaimBack

ClaimBack's free AI tool drafts a professional appeal letter in minutes, tailored to your insurer and denial reason. Don't let a denial be the final word.

Fight your denial at ClaimBack →

Related Reading:

• How to Write an Insurance Appeal Letter
• What Is Medical Necessity?
• What Is Step Therapy?